Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s stock price traded up 1% on Thursday . The company traded as high as $5.22 and last traded at $5.21. 8,164 shares changed hands during mid-day trading, a decline of 59% from the average session volume of 19,819 shares. The stock had previously closed at $5.1565.
Ono Pharmaceutical Stock Performance
The stock’s 50-day simple moving average is $4.71 and its 200 day simple moving average is $4.19.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.
Read More
- Five stocks we like better than Ono Pharmaceutical
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The day the gold market broke
- Your Bank Account Is No Longer Safe
- What a Former CIA Agent Knows About the Coming Collapse
- He just nailed another gold prediction …
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
